Journals Library

An error occurred retrieving content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

Adding adalimumab to methotrexate reduced the average risk over time of treatment failure in refractory uveitis associated with juvenile idiopathic arthritis by 75%.

{{author}}{{author}}{{($index < metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Athimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, Dyfrig A Hughes, Andrew McKay, Anna Rosala-Hallas, Paula R Williamson, Ben Hardwick, Helen Hickey, Naomi Rainford, Graeme Hickey, Ruwanthi Kolamunnage-Dona, Giovanna Culeddu, Catrin Plumpton, Eifiona Wood, Sandrine Compeyrot-Lacassagne, Patricia Woo, Clive Edelsten & Michael W Beresford.

Athimalaipet V Ramanan 1,2,*, Andrew D Dick 3,4,5, Ashley P Jones 6, Dyfrig A Hughes 7, Andrew McKay 6, Anna Rosala-Hallas 6, Paula R Williamson 6, Ben Hardwick 6, Helen Hickey 6, Naomi Rainford 6, Graeme Hickey 6, Ruwanthi Kolamunnage-Dona 6, Giovanna Culeddu 7, Catrin Plumpton 7, Eifiona Wood 7, Sandrine Compeyrot-Lacassagne 8, Patricia Woo 8, Clive Edelsten 8, Michael W Beresford 9,10

1 Department of Paediatric Rheumatology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
2 Bristol Medical School, University of Bristol, Bristol, UK
3 Bristol Eye Hospital, Bristol, UK
4 School of Clinical Sciences, University of Bristol, Bristol, UK
5 University College London Institute of Ophthalmology and National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London, UK
6 Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
7 Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK
8 Great Ormond Street Hospital, London, UK
9 Department of Paediatric Rheumatology, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
10 Department of Women’s and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
* Corresponding author Email:

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}{{metadata.DOI}}

Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.


Responses to this report

No responses have been published.


If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions